NDC 76329-8261-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76329-8261
- Requested NDC
- 76329-8261-01
- Package NDCs from labels
- 76329-8261-1, 76329-8261-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-03-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-03-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - International Medication Systems, Limited | International Medication Systems, Limited | 2024-03-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76329-8261-1 | Lorazepam | 10 mL in 1 VIAL | INJECTION | 10 | 13 | |
| 76329-8261-1 | Lorazepam | 10 in 1 CARTON | INJECTION | 10 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76329-8261 | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 13 | Current NDC, Legacy NDC, 2 package rows | 20240306_7dda070d-7809-46c4-8592-eb4e4c509707.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76329-8261-1 | ML - Milliliter | 76329-8261 | 434a2601-7460-488b-b472-386a13aa9343 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Lorazepam | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Lorazepam | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Benzyl Alcohol | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 | |
| Polyethylene glycol 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ITCH X | BENZYL ALCOHOL/PRAMOXINE HYDROCHLORIDE | BF ASCHER AND CO INC | 03c16d33-8f59-0184-e054-00144ff8d46c | 2024-12-05 | Warnings | LKG8494WBH |
| Salonpas LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Hisamitsu America, Inc. | 364924d3-fac3-4f4e-9b40-decd4ec48245 | 2024-12-03 | Warnings | LKG8494WBH |
| Salonpas LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Hisamitsu America, Inc. | ea5b4a7f-d47d-4dbd-9288-c01329e387e5 | 2024-12-03 | Warnings | LKG8494WBH |
| Orajel Toothache Rinse | BENZYL ALCOHOL, ZINC CHLORIDE | Church & Dwight Co., Inc. | 41709710-5392-3119-e054-00144ff88e88 | 2024-11-27 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | b2487467-a63f-48b5-b0de-3a6ce6672d50 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Meijer Pain Lidocaine Plus Relieving Analgesic | BENZYL ALCOHOL AND LIDOCAINE HYDROCHLORIDE | Meijer Distribution, Inc | b7385140-3f63-4cbc-b557-de1d29d1ea36 | 2024-11-15 | Warnings | LKG8494WBH |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | a9a90de6-3172-4d34-984b-f4442f880e3d | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | 2de7a41d-661d-495f-89b4-5690664a3a3d | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief Eye Drops | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | d9d3f000-3ce4-4ba2-a7fb-491b44eb3fa1 | 2024-11-13 | Warnings | B697894SGQ |
| Visine Dry Eye Relief | POLYETHYLENE GLYCOL 400 | Kenvue Brands LLC | a4c57620-778f-4434-9105-ead2f85c5884 | 2024-11-13 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 503834f9-fa2e-5e23-e054-00144ff88e88 | 2024-11-13 | Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | be85b116-9f09-403a-8e0d-e77e344d3a9a | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Chartwell RX, LLC | 6b0619c5-b9e9-47e7-97b5-7e581e67cf5f | 2024-11-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | ebdf72f7-7462-4b83-81b4-c7988860c728 | 2024-11-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | 9aa060f1-f8f6-46e6-a7d0-bd46a73f2676 | 2024-10-17 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8fa33078-c379-41f5-e053-2995a90acced | 2024-10-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dc1-3746-e054-00144ff8d46c | 2024-10-08 | Warnings, Adverse reactions | O26FZP769L |
| Fast Freeze Lidocaine Roll-On | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Natural Essentials, Inc. | 74b06366-5eb4-4eba-aa2b-2b672828294d | 2024-10-04 | Warnings | LKG8494WBH |
| CVS Health Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | NATURAL ESSENTIALS, INC. | 1adb9b74-4a01-4461-b845-f3aedcb3f810 | 2024-10-01 | Warnings | LKG8494WBH |
| 231dbd3a-331c-6c8f-e063-6394a90abf65 | 840a1d60-fe5b-4de3-9247-62185dd5b64f | 2024-09-27 | Boxed warning, Warnings, Adverse reactions | 840a1d60-fe5b-4de3-9247-62185dd5b64f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.